Medical device and MedTech insights, news, tips and more

Centinel Spine Announces IDE Approval of Two Different Prodisc C Devices

July 19, 2019

prodisc C Vivo & prodisc C SK

Centinel Spine said earlier this week that it won an investigational device exemption from the FDA for a clinical trial of its Prodisc cervical disc implants. New York City-based Centinel acquired the Prodisc assets from Johnson & Johnson subsidiary DePuy Synthes in December 2017 for an undisclosed amount. The FDA IDE covers a two-level study of the company Prodisc C Vivo and Prodisc C SK cervical implants for total disc replacement procedures, compared with an already-approved two-level TDR device. “Approval of the Prodisc C Vivo and Prodisc C SK products in the United States will enable Centinel Spine to provide the widest range of TDR products to surgeons and patients in the world. The Prodisc platform is the most clinically studied and proven TDR technology on the planet,” chairman & CEO John Viscogliosi said in prepared remarks. “The goal of Centinel Spine is to provide surgeons with multiple clinically proven TDR implant options to match a patient’s anatomy.” “Once available, the combination of endplate configurations for prodisc C Vivo and prodisc C SK will provide surgeons with the ability to adapt the implant used to the patient’s anatomy,” added Dr. Armen Khachatryan of Salt Lake City’s Disc Replacement Center. “Suiting the implant morphology to the patient anatomy provides me with a significant advantage as I seek to optimize patient clinical results and preserve spinal motion with arthroplasty.” See Full Article at the Source: Centinel Spine wins FDA nod for Prodisc implants trial – MassDevice

Article Written by: Brad Perriello
A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs. We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame. Are you hiring? Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.